Abbott Kaletra African AIDS Initiative Could Cost $800 Per Year
Executive Summary
Abbott expects the cost of the two HIV drugs it will offer through its distribution initiative in Africa, Kaletra and Norvir, to range between $800 and $1,000 per patient per year.